bioMérieux Dividends and Buybacks
Dividend criteria checks 0/6
bioMérieux is a dividend paying company with a current yield of 0.77%. Next payment date is on 11th June, 2025 with an ex-dividend date of 9th June, 2025.
Key information
0.8%
Dividend yield
0.3%
Buyback Yield
| Total Shareholder Yield | 1.0% |
| Future Dividend Yield | 1.1% |
| Dividend Growth | 12.8% |
| Next dividend pay date | 11 Jun 25 |
| Ex dividend date | 09 Jun 25 |
| Dividend per share | n/a |
| Payout ratio | 25% |
Recent dividend and buyback updates
Recent updates
These 4 Measures Indicate That bioMérieux (EPA:BIM) Is Using Debt Reasonably Well
May 07
bioMérieux S.A. (EPA:BIM) Not Lagging Market On Growth Or Pricing
Feb 11
FDA Approvals And Expansion Of Installed Base Will Drive Future Success
Feb 09 bioMérieux's strategic plan targets high growth in organic sales and EBIT, with improvements in revenue and net margins by enhancing operational efficiencies.A Look At The Intrinsic Value Of bioMérieux S.A. (EPA:BIM)
Jan 21Slowing Rates Of Return At bioMérieux (EPA:BIM) Leave Little Room For Excitement
Dec 10Is bioMérieux (EPA:BIM) Using Too Much Debt?
Nov 01Is There An Opportunity With bioMérieux S.A.'s (EPA:BIM) 31% Undervaluation?
Oct 14bioMérieux S.A.'s (EPA:BIM) Popularity With Investors Is Under Threat From Overpricing
Sep 26bioMérieux S.A. (EPA:BIM) Just Reported Interim Earnings: Have Analysts Changed Their Mind On The Stock?
Sep 08Return Trends At bioMérieux (EPA:BIM) Aren't Appealing
Aug 03bioMérieux S.A.'s (EPA:BIM) Price In Tune With Earnings
May 30Upcoming Dividend Payment
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: BIM is not paying a notable dividend for the French market, therefore no need to check if payments are stable.
Growing Dividend: BIM is not paying a notable dividend for the French market, therefore no need to check if payments are increasing.
Dividend Yield vs Market
| bioMérieux Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (BIM) | 0.8% |
| Market Bottom 25% (FR) | 2.1% |
| Market Top 25% (FR) | 5.4% |
| Industry Average (Medical Equipment) | 1.7% |
| Analyst forecast (BIM) (up to 3 years) | 1.1% |
Notable Dividend: BIM's dividend (0.77%) isn’t notable compared to the bottom 25% of dividend payers in the French market (2.11%).
High Dividend: BIM's dividend (0.77%) is low compared to the top 25% of dividend payers in the French market (5.41%).
Earnings Payout to Shareholders
Earnings Coverage: BIM is not paying a notable dividend for the French market.
Cash Payout to Shareholders
Cash Flow Coverage: BIM is not paying a notable dividend for the French market.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/11 04:39 |
| End of Day Share Price | 2025/05/09 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
bioMérieux S.A. is covered by 33 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Armelle Moulin | AlphaValue |
| Gaurav Jain | Barclays |
| Thomas Jones | Berenberg |